{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.210","meta":{"versionId":"12","lastUpdated":"2022-01-12T01:02:12.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210","version":"20220112","name":"Capecitabine Oral","status":"active","date":"2022-01-12T01:02:12-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"200327","display":"capecitabine 150 MG Oral Tablet"},{"code":"200328","display":"capecitabine 500 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:c674a036-7bfc-41db-967e-6dd826643208","timestamp":"2022-06-10T05:27:17-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"200327","display":"capecitabine 150 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"200328","display":"capecitabine 500 MG Oral Tablet"}]}}